{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:40:04Z","timestamp":1739148004624,"version":"3.37.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1007\/bf03044707","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T03:05:24Z","timestamp":1244257524000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiphospholipidantik\u00f6rpersyndrom","Antiphospholipid antibody syndrome"],"prefix":"10.1007","volume":"94","author":[{"given":"R\u00fcdiger","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst-Heinrich","family":"Scheuermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Viertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Scharrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03044707_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","volume":"68","author":"D Alarcon-Segovia","year":"1989","unstructured":"Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the anti-phospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353\u201365.","journal-title":"Medicine (Baltimore)"},{"key":"BF03044707_CR2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1653866","volume":"73","author":"PR Ames","year":"1995","unstructured":"Ames PR, Pyke S, Iannaccone L, et al. et al. Antiphospholipid antibodies, haemostatic variables and thrombosis \u2014 a survey of 144 patients. Thromb Haemost 1995;73:768\u201373.","journal-title":"Thromb Haemost"},{"key":"BF03044707_CR3","first-page":"1","volume":"1","author":"RA Asherson","year":"1986","unstructured":"Asherson RA, Oakley C Pulmonary hypertension in SLE. J Rheumatol 1986;1:1\u20136.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.46.8.605","volume":"46","author":"RA Asherson","year":"1987","unstructured":"Asherson RA, Mercy D, Phillips G, et al. Recurrent stroke and multi-infarct dementia in SLE associated with antiphospho-lipid antibodies. Ann Rheum Dis. 46 (1987), 605\u2013611.","journal-title":"Ann Rheum Dis"},{"key":"BF03044707_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/ard.44.12.823","volume":"44","author":"R.A. Asherson","year":"1985","unstructured":"Asherson R.A., E.N. Harris, A.E. Gharavi, G.R.V. Hughes: Anticardiolipin antibody, recurrent thrombosis and warfarin withdrawel. Ann Rheum Dis 1985;44:823\u20135.","journal-title":"Ann Rheum Dis"},{"key":"BF03044707_CR6","first-page":"284","volume":"29","author":"RA Asherson","year":"1993","unstructured":"Asherson RA, Liote F, Page B. Aseptic necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993;29:284\u20138.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR7","first-page":"377","volume":"15","author":"RA Asherson","year":"1988","unstructured":"Asherson RA, Hughes GRV. Antiphospholipid antibodies and chorea. J Rheumatol 1988;15:377\u20139.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR8","first-page":"1268","volume":"28","author":"RA Asherson","year":"1993","unstructured":"Asherson RA, Kant KS. Antiphospholipid antibodies and the kidney. J Rheumatol 1993;28:1268\u201372.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR9","first-page":"1103","volume":"73","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Baguley E, et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med 1989;73:1103\u20135.","journal-title":"Q J Med"},{"key":"BF03044707_CR10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","volume":"68","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Ordi-Ros J, R et al. The primary antiphospho-lipid-syndrome: Major clinical and serological features. Medicine (Baltimore) 1989;68:366\u201374.","journal-title":"Medicine (Baltimore)"},{"key":"BF03044707_CR11","first-page":"212","volume":"120","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Mayou SC, Merry P, et al. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol 1989;120:212\u20135.","journal-title":"Br J Dermatol"},{"key":"BF03044707_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/ard.45.5.435","volume":"45","author":"M Averbach","year":"1986","unstructured":"Averbach M, Levo Y. Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with lupus anticoagulant. Ann Rheum Dis 1986;45:435\u20137.","journal-title":"Ann Rheum Dis"},{"key":"BF03044707_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/000331978503600705","volume":"36","author":"E Badui","year":"1985","unstructured":"Badui E, Garcia-Rubi D, Robles E, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36:431\u201341.","journal-title":"Angiology"},{"key":"BF03044707_CR14","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/oxfordjournals.humrep.a138009","volume":"8","author":"J Balasch","year":"1998","unstructured":"Balasch J, Carmona F, Lopez-Soto A, et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1998;8:2234\u20139.","journal-title":"Hum Reprod"},{"key":"BF03044707_CR15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0272-6386(12)80885-7","volume":"58","author":"G Banfi","year":"1991","unstructured":"Banfi G, Bertani T, Boeri V, et al. for the Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991;58:240\u20138.","journal-title":"Am J Kidney Dis"},{"key":"BF03044707_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2007-1001885","volume":"20","author":"RL Bick","year":"1994","unstructured":"Bick RL, Baker WF. Antiphospholipid and thrombosis syndromes. Semin Thromb Hemostas 1994;20:3\u201315.","journal-title":"Semin Thromb Hemostas"},{"key":"BF03044707_CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcp\/100.5.477","volume":"100","author":"RL Bick","year":"1993","unstructured":"Bick RL. The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversy. Am J Clin Pathol 1993;100:477\u201380.","journal-title":"Am J Clin Pathol"},{"key":"BF03044707_CR18","first-page":"416","volume":"62","author":"EJW Bowie","year":"1963","unstructured":"Bowie EJW, Thompson JH, Pascuzzi CA, et al. Thrombosis in systemic lupus erythematodes despite circulating anticoagulant. J Lab Clin Med 1963;62:416\u201330.","journal-title":"J Lab Clin Med"},{"key":"BF03044707_CR19","first-page":"541","volume":"73","author":"DW Branch","year":"1989","unstructured":"Branch DW, Andres R, Digre KB, et al. The association of anti-phospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989;73:541\u20135.","journal-title":"Obstet Gynecol"},{"key":"BF03044707_CR20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","volume":"74","author":"JT Brandt","year":"1995","unstructured":"Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185\u201390.","journal-title":"Thromb Haemost"},{"key":"BF03044707_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.410250303","volume":"25","author":"DP Briley","year":"1989","unstructured":"Briley DP, Coull BM, Goodnight SH. Neurologic disease associated with antiphospholipid antibodies. Ann Neurol 1989;25:221\u20137.","journal-title":"Ann Neurol"},{"key":"BF03044707_CR22","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/bmj.296.6635.1505","volume":"296","author":"JH Brown","year":"1988","unstructured":"Brown JH, Doherty CC, Allen DC, et al. Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. Br Med J 1988;296:1505.","journal-title":"Br Med J"},{"key":"BF03044707_CR23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/ki.1995.352","volume":"48","author":"P Brunet","year":"1995","unstructured":"Brunet P, Aillaud MF, San-Marco M, et al. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int 1995;48:794\u2013800.","journal-title":"Kidney Int"},{"key":"BF03044707_CR24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0897.1992.tb00789.x","volume":"28","author":"NMM Buchanan","year":"1992","unstructured":"Buchanan NMM, Khamashta MA, Morton KE, et al. A study of 100 high risk lupus pregnancies. Am J Reprod Immunol 1992;28:192\u20134.","journal-title":"Am J Reprod Immunol"},{"key":"BF03044707_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1445-5994.1991.tb03002.x","volume":"21","author":"JN Burrow","year":"1991","unstructured":"Burrow JN, Blumbergs PC, Iyer PV, et al. Kohlmeier-Degos disease: a multisystem vasculopathy with progressive cerebral infarction. Aust NZ J Med 1991;21:49\u201351.","journal-title":"Aust NZ J Med"},{"key":"BF03044707_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ajh.2830270408","volume":"27","author":"RT Canoso","year":"1988","unstructured":"Canoso RT, deOliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant. Absense of thrombosis. Am J Hematol 1988;27:272\u20135.","journal-title":"Am J Hematol"},{"key":"BF03044707_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/ard.48.5.430","volume":"48","author":"S Carette","year":"1989","unstructured":"Carette S, Jobin F. Acute adrenal insufficiancy as a manifestation of the anticardiolipin syndrome? Ann Rheum Dis 1989;48:430\u20131.","journal-title":"Ann Rheum Dis"},{"key":"BF03044707_CR28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1471-0528.1981.tb02224.x","volume":"88","author":"LO Carreras","year":"1981","unstructured":"Carreras LO, Vermylen J, Spitz B. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981;88:890\u20134.","journal-title":"Br J Obstet Gynaecol"},{"key":"BF03044707_CR29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R Cervera","year":"1993","unstructured":"Cervera R, Khamashta MA, Font J, et al. and the European Working Party on Systemic Lupus Erythematosus: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1.000 patients. Medicine (Baltimore) 1993;72:113\u201324.","journal-title":"Medicine (Baltimore)"},{"key":"BF03044707_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0002-9343(89)90337-9","volume":"86","author":"EK Chartash","year":"1989","unstructured":"Chartash EK, Lans DM, Paget SA, et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989;86:407\u201312.","journal-title":"Am J Med"},{"key":"BF03044707_CR31","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/hep.1840200614","volume":"20","author":"A Chedid","year":"1994","unstructured":"Chedid A, Chadalawada KR, Morgan TR, et al. Phospholipid antibodies in alcoholic liver disease Hepatology 1994;20:1465\u201371.","journal-title":"Hepatology"},{"key":"BF03044707_CR32","first-page":"621","volume":"31","author":"CL Conley","year":"1952","unstructured":"Conley CL, Hartman RC. Haemorrhagic disorder caused by circulating anticoagulant in patients with dissiminated lupus erythematosus. J Clin Invest 1952;31:621\u20132.","journal-title":"J Clin Invest"},{"key":"BF03044707_CR33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","volume":"166","author":"FS Cowchock","year":"1992","unstructured":"Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal loss associated with antiphospholipid antibodes: a collaborative randomized trial comparing prednisolone to low dose heparin treatment. Am J Obstet Gynecol 1992;166:1318\u201323.","journal-title":"Am J Obstet Gynecol"},{"key":"BF03044707_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2133.1991.tb06065.x","volume":"125","author":"NH Cox","year":"1991","unstructured":"Cox NH, Long E. Dowling-Degos disease and Kitamura\u2019s reticulate acropigmentation: support for the concept of a single disease. Br J Dermatol 1991;125:169\u201371.","journal-title":"Br J Dermatol"},{"key":"BF03044707_CR35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.STR.16.3.512","volume":"16","author":"JG D\u2019Alton","year":"1985","unstructured":"D\u2019Alton JG, Preston DN, Bormanis J. Multiple transient ischaemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985;16:512\u20134.","journal-title":"Stroke"},{"key":"BF03044707_CR36","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/art.1780371018","volume":"37","author":"J de-la-Mata","year":"1994","unstructured":"de-la-Mata J, Gomez-Sanchez MA, Aranzana M, et al. Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum 1994;37:1528\u201333.","journal-title":"Arthritis Rheum"},{"key":"BF03044707_CR37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0038-1642699","volume":"74","author":"T Exner","year":"1995","unstructured":"Exner T. Diagnostic methodologies for circulating anticoagulants. Thromb Haemost 1995;74:338\u201344.","journal-title":"Thromb Haemost"},{"key":"BF03044707_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1600-0609.1994.tb00195.x","volume":"53","author":"F Fabris","year":"1994","unstructured":"Fabris F, Steffan A, Cordiano I, et al. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia. Eur J Haematol 1994;53:232\u20136.","journal-title":"Eur J Haematol"},{"key":"BF03044707_CR39","first-page":"75","volume":"1","author":"DI Feinstein","year":"1972","unstructured":"Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972;1:75\u201395.","journal-title":"Prog Hemost Thromb"},{"key":"BF03044707_CR40","first-page":"623","volume":"16","author":"RA Fields","year":"1989","unstructured":"Fields RA, Toubbeh H, Searles RP, et al. The prevalence of anticardiolipid antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623\u20135.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/path.1711190202","volume":"15","author":"B Fox","year":"1976","unstructured":"Fox B. Venous infarction of the adrenal glands. J Pathol 1976;15:65\u201387.","journal-title":"J Pathol"},{"key":"BF03044707_CR42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V10.7.691.691","volume":"10","author":"PG Frick","year":"1955","unstructured":"Frick PG. Acquired circulating anticoagulants in systemic \u201ccollagen disease\u201d. Blood 1955;10:691\u2013706.","journal-title":"Blood"},{"key":"BF03044707_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0167-5273(95)02357-3","volume":"51","author":"F Gabrielli","year":"1995","unstructured":"Gabrielli F, Alcini E, Di-Prima MA, et al. Cardiac valve involve-ment in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995;51:117\u201326.","journal-title":"Int J Cardiol"},{"key":"BF03044707_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/096120339400300404","volume":"3","author":"M Galli","year":"1994","unstructured":"Galli M, Bevers EM. Inhibition of phospholipid-dependent coagulation reactions by antiphospholipid antibodies: possible mechanisms of action. Lupus 1994;3:223\u20138.","journal-title":"Lupus"},{"key":"BF03044707_CR45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","volume":"116","author":"E Galve","year":"1992","unstructured":"Galve E, Ordi J, Barquinero J, et al. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293\u20138.","journal-title":"Ann Intern Med"},{"key":"BF03044707_CR46","first-page":"1406","volume":"20","author":"S Ghosh","year":"1993","unstructured":"Ghosh S, Walters HD, Joist JH, et al. Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome. J Rheumatol 1993;20:1406\u20138.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR47","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","volume":"86","author":"JS Ginsberg","year":"1995","unstructured":"Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685\u201391.","journal-title":"Blood"},{"key":"BF03044707_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0002-9343(99)80222-8","volume":"99","author":"SN Goldberg","year":"1995","unstructured":"Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995;99:473\u20139.","journal-title":"Am J Med"},{"key":"BF03044707_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/jnp.5.1.37","volume":"5","author":"DG Gorman","year":"1993","unstructured":"Gorman DG, Cummings JL. Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiat Clin Neurosci 1993;5:37\u201342.","journal-title":"J Neuropsychiat Clin Neurosci"},{"key":"BF03044707_CR50","first-page":"152","volume":"10","author":"CE Grattan","year":"1991","unstructured":"Grattan CE, Burton JL. Antiphospholipid syndrome and cutaneous vasoocclusive disorders. Semin Dermatol 1991;10:152\u20139.","journal-title":"Semin Dermatol"},{"key":"BF03044707_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archinte.151.2.389","volume":"1521","author":"SG Greisman","year":"1991","unstructured":"Greisman SG, Thayaparan RS, Godwin TA, et al. Occlusiv vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch Intern Med 1991;1521:389\u201392.","journal-title":"Arch Intern Med"},{"key":"BF03044707_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0006-291X(74)90371-4","volume":"58","author":"M Guanieri","year":"1974","unstructured":"Guanieri M, Eisner D. A DNA antigen that reacts with antisera to cardiolipin. Biochem Biophys Res Commun 1974;58:347\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03044707_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0140-6736(86)92258-0","volume":"1","author":"A Hamsten","year":"1986","unstructured":"Hamsten A, Norberg R, Bj\u00f6rkholm M, et al. Antibodies to cardiolipin in young survivors of myocardial infarction. Lancet 1986;1:113\u20136.","journal-title":"Lancet"},{"key":"BF03044707_CR54","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1001\/archinte.146.11.2153","volume":"146","author":"EN Harris","year":"1986","unstructured":"Harris EN, Chan JKH, Asherson RA. Thrombosis, recurrent fetal loss, and thrombocytopenia: Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153\u20136.","journal-title":"Arch Intern Med"},{"key":"BF03044707_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2141.1985.tb02988.x","volume":"59","author":"EN Harris","year":"1985","unstructured":"Harris EN, Gharavi AE, Asherson RA. Thrombocytopenia in SLE and related autoimmun disorders: Association with anticardiolipin antibody. Br J Haematol 1985;59:227\u201330.","journal-title":"Br J Haematol"},{"key":"BF03044707_CR56","first-page":"804","volume":"83","author":"M Hochfeld","year":"1994","unstructured":"Hochfeld M, Druzin M, Maia D, et al. Pregnancy complicated by primary antiphospholipid antibody syndrome. Obstet Gynecol 1994;83:804\u20135.","journal-title":"Obstet Gynecol"},{"key":"BF03044707_CR57","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198505303122206","volume":"312","author":"DC Homans","year":"1985","unstructured":"Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985;312:1432\u20137.","journal-title":"N Engl J Med"},{"key":"BF03044707_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/096120339600500601","volume":"5","author":"GRV Hughes","year":"1996","unstructured":"Hughes GRV. The antiphospholipid syndrome. Lupus 1996;5:345\u20136.","journal-title":"Lupus"},{"key":"BF03044707_CR59","doi-asserted-by":"crossref","first-page":"974","DOI":"10.7326\/0003-4819-116-12-974","volume":"116","author":"N Kattwinkel","year":"1992","unstructured":"Kattwinkel N, Villanueva AG, Labib SB, et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992;116:974\u20136.","journal-title":"Ann Intern Med"},{"key":"BF03044707_CR60","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00002281-199509000-00005","volume":"7","author":"MA Khamashta","year":"1995","unstructured":"Khamashta MA, Hughes GRH. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995;7:389\u201394.","journal-title":"Curr Opin Rheumatol"},{"key":"BF03044707_CR61","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM199504133321504","volume":"332","author":"MA Khamastha","year":"1995","unstructured":"Khamastha MA, Cuadrado MJ, Mujic F,, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993\u20137.","journal-title":"N Engl J Med"},{"key":"BF03044707_CR62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000168432","volume":"12","author":"D Kniaz","year":"1992","unstructured":"Kniaz D, Eisenberg GM, Elrad H, et al. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. Am J Nephrol 1992;12:126\u201333.","journal-title":"Am J Nephrol"},{"key":"BF03044707_CR63","first-page":"1229","volume":"20","author":"D Le-Thi-Huong","year":"1993","unstructured":"Le-Thi-Huong D, Wechsler B, Edelman P, et al. Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid antibody syndrome. J Rheumatol 1993;20:1229\u201332.","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"BF03044707_CR64","first-page":"29","volume":"23","author":"SR Levine","year":"1992","unstructured":"Levine, SR, Brey RL, Joseph CLM, et al. on behalf of the Antiphospholipid Antibodies in Stroke Study Group: Risk of thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992;23:Suppl 1:29\u201332.","journal-title":"Stroke"},{"key":"BF03044707_CR65","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","volume":"313","author":"MD Lockshin","year":"1985","unstructured":"Lockshin MD, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152\u20136.","journal-title":"N Engl J Med"},{"key":"BF03044707_CR66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-857X(21)00179-4","volume":"19","author":"MD Lockshin","year":"1993","unstructured":"Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993;19:235\u201347.","journal-title":"Rheum Dis Clin North Am"},{"key":"BF03044707_CR67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9378(89)90522-X","volume":"161","author":"CJ Lockwood","year":"1989","unstructured":"Lockwood CJ, Romero R, Feinberg RF, et al. The prevalence and significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetic population. Am J Obstet Gynecol 1989;161:369\u201373.","journal-title":"Am J Obstet Gynecol"},{"key":"BF03044707_CR68","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/ard.48.5.362","volume":"48","author":"CG Mackworth-Young","year":"1989","unstructured":"Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid-syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989;48:362\u20137.","journal-title":"Ann Rheum Dis"},{"key":"BF03044707_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0168-8278(86)80150-7","volume":"3","author":"CG Mackworth-Young","year":"1986","unstructured":"Mackworth-Young CG, Melia WM, Harris E, et al. The Budd-Chiari syndrome. Possible pathogenetic role of antiphospholipid antibodies. J Hepatol 1986;3:83\u20136.","journal-title":"J Hepatol"},{"key":"BF03044707_CR70","first-page":"1277","volume":"8","author":"M Mandreoli","year":"1993","unstructured":"Mandreoli M, Zucchelli P. Renal vascular diseasea in patients with primary antiphospholipid antibodies. Nephrol Dial Transplant 1993;8:1277\u201380.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03044707_CR71","first-page":"557","volume":"69","author":"MN Manoussakis","year":"1987","unstructured":"Manoussakis MN, Tzioufas AG, Silis MP. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987;69:557\u201365.","journal-title":"Clin Exp Immunol"},{"key":"BF03044707_CR72","first-page":"1138","volume":"90","author":"J Matsuda","year":"1995","unstructured":"Matsuda J, Saitoh N, Gotoh M, et al. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha. Am J Gastroenterol 1995;90:1138\u201341.","journal-title":"Am J Gastroenterol"},{"key":"BF03044707_CR73","first-page":"637","volume":"11","author":"R Mazzucchelli","year":"1993","unstructured":"Mazzucchelli R, Barbadillo C, Yousset H, et al. Catastrophic antiphospholipid syndrome: a rare manifestation of the antiphospholipid antibody syndrome. Clin Exp Rheumatol 1993;11:637\u201357.","journal-title":"Clin Exp Rheumatol"},{"key":"BF03044707_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-2776(08)60777-4","volume":"49","author":"HP McNeil","year":"1991","unstructured":"McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49:193\u2013280.","journal-title":"Adv Immunol"},{"key":"BF03044707_CR75","first-page":"425","volume":"8","author":"HP McNeil","year":"1990","unstructured":"McNeil HP, Gravaghan TP, Krilis SA, et al. HLA-DR antigens and anticardiolipin antibodies. Clin Exp Rheumatol 1990;8:425\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"BF03044707_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/096120339400300108","volume":"3","author":"S Migliaresi","year":"1994","unstructured":"Migliaresi S, Picillo U, Ambrosone L, et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994;3:37\u201341.","journal-title":"Lupus"},{"key":"BF03044707_CR77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/096120339400300106","volume":"3","author":"JM Miranda","year":"1994","unstructured":"Miranda JM, Garcia-Torres R, Jara LJ, et al. Renal biopsy in systemic lupus erythematosus. Analysis of 108 cases. Lupus 1994;3:25\u20139.","journal-title":"Lupus"},{"key":"BF03044707_CR78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0012.1994.tb00952.x","volume":"8","author":"G Mondragon-Ramirez","year":"1994","unstructured":"Mondragon-Ramirez G, Bochicchio T, Garcia-Torres R, et al. Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS). Clin Transplant 1994;8:93\u20136.","journal-title":"Clin Transplant"},{"key":"BF03044707_CR79","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.STR.22.6.750","volume":"22","author":"J Montalban","year":"1991","unstructured":"Montalban J, Codina A, Ordi J, et al. Antiphospholipid antibodies in cerebral ischaemia. Stroke 1991;22:751\u20133.","journal-title":"Stroke"},{"key":"BF03044707_CR80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/jama.1952.03680050033010","volume":"150","author":"JE Moore","year":"1952","unstructured":"Moore JE, Mohr CF. Biologically false positive serologic tests for syphilis. JAMA 1952;150:467\u201373.","journal-title":"JAMA"},{"key":"BF03044707_CR81","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0140-6736(86)92004-0","volume":"2","author":"KE Morton","year":"1986","unstructured":"Morton KE, Gavahan TP, Kirilis SA. Coronary artery bypass graft failure: An autoimmune phenomenon? Lancet 1986;2:1353\u20136.","journal-title":"Lancet"},{"key":"BF03044707_CR82","first-page":"1589","volume":"22","author":"F Mujic","year":"1995","unstructured":"Mujic F, Cuadrado MJ, Lloyd M, et al. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995;22:1589\u201392.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR83","first-page":"254","volume":"38","author":"JF M\u00fcller","year":"1951","unstructured":"M\u00fcller JF, Ratnoff O, Heinle RW. Observations on the characteristics of an unusual circulating anticoagulant. J Lab Clin Med 1951;38:254\u201361.","journal-title":"J Lab Clin Med"},{"key":"BF03044707_CR84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/ard.52.3.219","volume":"52","author":"L Naldi","year":"1993","unstructured":"Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 1993;52:219\u201322.","journal-title":"Ann Rheum Dis"},{"key":"BF03044707_CR85","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0002-8703(94)90760-9","volume":"128","author":"GA Nickele","year":"1994","unstructured":"Nickele GA, Foster PA, Kenny D. Primary antiphospholipid syndrome and mitral valve thrombosis. Am Heart J 1994;128:1245\u20137.","journal-title":"Am Heart J"},{"key":"BF03044707_CR86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.82.2.369","volume":"82","author":"P Nihoyannopoulos","year":"1990","unstructured":"Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990;82:369\u201375.","journal-title":"Circulation"},{"key":"BF03044707_CR87","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/hrt.70.3.279","volume":"70","author":"S O\u2019Hickey","year":"1993","unstructured":"O\u2019Hickey S, Skinner C, Beattie J. Life-threatening right ventricular thrombosis in association with phospholipid antibodies. Br Heart J 1993;70:279\u201381.","journal-title":"Br Heart J"},{"key":"BF03044707_CR88","first-page":"1360","volume":"21","author":"MH Ornstein","year":"1994","unstructured":"Ornstein MH, Rand JH. An association between refractory HELLP-syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases. J Rheumatol 1994;21:1360\u20134.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9378(11)91619-6","volume":"167","author":"HJ Out","year":"1992","unstructured":"Out HJ, Bruinse HW, Christiaens GC, et al. A prospective, controlled multicenter study on the obstetic risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26\u201332.","journal-title":"Am J Obstet Gynecol"},{"key":"BF03044707_CR90","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3181\/00379727-48-13365P","volume":"48","author":"MC Pangborn","year":"1941","unstructured":"Pangborn MC. A new serologically active phopholipid from beef heart. Proc Soc Exp Biol Med 1941;48:484\u20136.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF03044707_CR91","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00000441-199405000-00007","volume":"307","author":"NW Peacock","year":"1994","unstructured":"Peacock NW, Levine SP. Case report: The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sci 1994;307:346\u20139.","journal-title":"Am J Med Sci"},{"key":"BF03044707_CR92","first-page":"238","volume":"35","author":"S Pelletier","year":"1992","unstructured":"Pelletier S, Landi B, Piette JC. The antiphospholipid syndrome as the second cause of non-malignant Budd-Chiari syndrome. Arthritis Rheum 1992;35:S 238.","journal-title":"Arthritis Rheum"},{"key":"BF03044707_CR93","first-page":"1289","volume":"19","author":"RE Perez","year":"1992","unstructured":"Perez RE, McClendon JR. Primary antiphospholipid syndrom with multiorgan arterial and venous thrombosis. J Rheumatol 1992;19:1289\u201392.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR94","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0002-9343(92)90264-C","volume":"92","author":"ME Perez-Vasquez","year":"1992","unstructured":"Perez-Vasquez ME, Cabiedes J, Cabral AR, et al. Decrease in serum antiphospholipid antibody levels upon developement of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors. Am J Med 1992;92:357\u201362.","journal-title":"Am J Med"},{"key":"BF03044707_CR95","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0049-0172(94)90086-8","volume":"23","author":"JC Piette","year":"1994","unstructured":"Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994;23:357\u201366.","journal-title":"Semin Arthritis Rheum"},{"key":"BF03044707_CR96","first-page":"1108","volume":"78","author":"WJ Polzin","year":"1991","unstructured":"Polzin WJ, Kopelman JN, Robinson RD, et al. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991;78:1108\u201311.","journal-title":"Obstet Gynecol"},{"key":"BF03044707_CR97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(91)90569-J","volume":"90","author":"JM Pope","year":"1991","unstructured":"Pope JM, Canny CL, Bell DA. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med 1991;90:299\u2013309.","journal-title":"Am J Med"},{"key":"BF03044707_CR98","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0272-6386(12)80378-7","volume":"23","author":"C Quereda","year":"1994","unstructured":"Quereda C, Otero GG, Pardo A, et al. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Am J Kidney Dis 1994;23:555\u201361.","journal-title":"Am J Kidney Dis"},{"key":"BF03044707_CR99","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0272-6386(12)80986-3","volume":"23","author":"J Radhakrishnan","year":"1994","unstructured":"Radhakrishnan J, Williams GS, Appel GB, et al. Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kidney Dis 1994;23:286\u20139.","journal-title":"Am J Kidney Dis"},{"key":"BF03044707_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/096120339400300205","volume":"3","author":"G Rivier","year":"1995","unstructured":"Rivier G, Herranz MT, Kamashta MA, et al. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1995;3:85\u201390.","journal-title":"Lupus"},{"key":"BF03044707_CR101","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0038-1651083","volume":"57","author":"E Rosner","year":"1987","unstructured":"Rosner E, Pauzner R, Lusky A, et al. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987;57:144\u20137.","journal-title":"Thromb Haemost"},{"key":"BF03044707_CR102","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","volume":"117","author":"MH Rosove","year":"1992","unstructured":"Rosove MH, Harris EN, Gharavi AE, et al. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303\u20138.","journal-title":"Ann Intern Med"},{"key":"BF03044707_CR103","first-page":"623","volume":"19","author":"J Sanchez-Guerrero","year":"1992","unstructured":"Sanchez-Guerrero J, Reves E, Alarcon-Segovia D. Primary antiphospholipid syndrome as cause of intestinal infarction. J Rheumatol 1992;19:623\u20135.","journal-title":"J Rheumatol"},{"key":"BF03044707_CR104","unstructured":"Scharrer I. Diagnostik und Bedeutung der Lupus-Antikoagulantien. In: Keller F, Hrsg. Neue Aspekte der H\u00e4mostaseologie. Xxxxx: Medizinische Verlagsgesellschaft, 1996:72\u20138."},{"key":"BF03044707_CR105","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0002-9378(93)90410-K","volume":"169","author":"RK Silver","year":"1993","unstructured":"Silver RK, MacGregor SN, Sholl JS, et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"BF03044707_CR106","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00005792-199207000-00004","volume":"71","author":"G Sturfelt","year":"1992","unstructured":"Sturfelt G, Eskilsson J, Nived O, et al. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients from a defined population. Medicine (Baltimore) 1992;71:216\u201323.","journal-title":"Medicine (Baltimore)"},{"key":"BF03044707_CR107","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1600-0404.1988.tb03673.x","volume":"78","author":"J Syrjanen","year":"1988","unstructured":"Syrjanen J, Vaarala O, Iivanainen M. Anticardiolipin response and its association with infections in young and middle aged patients with cerebral infarction. Acta Neurol Scand 1988;78:381\u20136.","journal-title":"Acta Neurol Scand"},{"key":"BF03044707_CR108","first-page":"66","volume":"14","author":"S Tabbutt","year":"1994","unstructured":"Tabbutt S, Griswold WR, Ogino MT, et al. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. Perinatology 1994;14:66\u201370.","journal-title":"Perinatology"},{"key":"BF03044707_CR109","first-page":"27","volume":"42","author":"K Tada","year":"1995","unstructured":"Tada K, Akamatsu K, Konno T, et al. Clinical significance of antiphospholipid antibodies in fulminant hepatic failure. Hepatogastroenterology 1995;42:27\u201330.","journal-title":"Hepatogastroenterology"},{"key":"BF03044707_CR110","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1172\/JCI109869","volume":"66","author":"P Thiagarajan","year":"1980","unstructured":"Thiagarajan P, Shapiro SS, DeMarco L. A monoclonal IgM coagulation inhibitor with phospholipid specificity: Mechanism of a lupus anticoagulant. J Clin Invest 1980;66:397\u2013405.","journal-title":"J Clin Invest"},{"key":"BF03044707_CR111","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0006-3223(94)90051-5","volume":"35","author":"P Toren","year":"1994","unstructured":"Toren P, Toren A, Weizman A, et al. Tourette\u2019s disorder: is there an association with the antiphospholipid syndrome? Biol Psychiat 1994;35:495\u20138.","journal-title":"Biol Psychiat"},{"key":"BF03044707_CR112","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0038-1642698","volume":"74","author":"DA Triplett","year":"1995","unstructured":"Triplett DA. Protean clinical presentation of antiphospholipid-protein-antibodies (APA). Thromb Haemostas 1995;74:329\u201337.","journal-title":"Thromb Haemostas"},{"key":"BF03044707_CR113","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-3083.1988.tb01493.x","volume":"28","author":"O Vaarala","year":"1988","unstructured":"Vaarala O, Vaara M, Palosua T. Effective inhibition of cardiolipin-binding antibodiesin gram-negative infection by bacterial lipopolysaccharide. Scand J Immunol 1988;28:607\u201312.","journal-title":"Scand J Immunol"},{"key":"BF03044707_CR114","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0308-2261(18)30023-7","volume":"15","author":"J Vermylen","year":"1986","unstructured":"Vermylen J, Blockmans D, Spitz B, et al. Thrombosis and immune disorder. Clin Haematol 1986;15:393\u2013412.","journal-title":"Clin Haematol"},{"key":"BF03044707_CR115","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","volume":"96","author":"JL Vianna","year":"1994","unstructured":"Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syn drome: a European Multicenter Study of 114 patients. Am J Med 1994;96:3\u20139.","journal-title":"Am J Med"},{"key":"BF03044707_CR116","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.248.19.2493","volume":"248","author":"CC Waddell","year":"1982","unstructured":"Waddell CC, Brown JA. The lupus anticoagulant in 14 male patients. JAMA 1982;248:2493\u20135.","journal-title":"JAMA"},{"key":"BF03044707_CR117","first-page":"1599","volume":"44","author":"A. Wassermann","year":"1907","unstructured":"Wassermann A. \u00dcber die Entwicklung und den gegenw\u00e4rtigen Stand der Serodiagnostik gegen\u00fcber Syphilis. Berl Klin Wochenschr 1907;44:1599.","journal-title":"Berl Klin Wochenschr"},{"key":"BF03044707_CR118","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/j.1875-9114.1995.tb04391.x","volume":"15","author":"AK Wittkowsky","year":"1995","unstructured":"Wittkowsky AK, Kino KJ. Heparin monitoring in acute thrombosis associated with antiphospholipid antibody syndrome. Pharmacotherapy 1995;15:517\u201321.","journal-title":"Pharmacotherapy"},{"key":"BF03044707_CR119","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-91-2-194","volume":"91","author":"M Zarrabi","year":"1979","unstructured":"Zarrabi M, Zucker S, Miller F. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med 1979;91:194\u20139.","journal-title":"Ann Intern Med"},{"key":"BF03044707_CR120","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/archderm.129.4.437","volume":"129","author":"B Zelger","year":"1993","unstructured":"Zelger B, Sepp N, Stockhammer G, et al. Sneddon\u2019s syndrome. A long-term follow-up of 21 patients. Arch Dermatol 1993;129:437\u201347.","journal-title":"Arch Dermatol"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03044707\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T23:58:27Z","timestamp":1739145507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03044707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BF03044707"],"URL":"https:\/\/doi.org\/10.1007\/bf03044707","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"type":"print","value":"0723-5003"},{"type":"electronic","value":"1615-6722"}],"subject":[],"published":{"date-parts":[[1999,2]]},"assertion":[{"value":"1 July 1997","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 1998","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}